Glass House Brands (GLAS) Intangibles (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Intangibles of $11.6 million for Q1 2026, down 4.08% year-over-year from $12.1 million in Q1 2025, and little changed quarter-over-quarter from $11.6 million in Q4 2025.
Glass House Brands (GLAS) Intangibles (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Intangibles for 7 consecutive years, with $11.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles fell 4.08% year-over-year to $11.6 million; the TTM figure through Mar 2026 stood at $11.6 million (down 4.08% YoY), while the FY2025 annual figure was $11.6 million, down 18.47% from the prior year.
- Intangibles was little changed at $11.6 million in Q1 2026 per GLAS's latest filing, from $11.6 million in the prior quarter.
- Across five years, Intangibles topped out at $47.2 million in Q3 2022 and bottomed at $5.6 million in Q1 2022.
- Historically, Intangibles has averaged $20.2 million across 5 years, with a median of $20.9 million in 2024.
- On a YoY basis, Intangibles climbed as much as 4410.07% in 2022 and fell as far as 96.84% in 2022.
- Glass House Brands' Intangibles stood at $26.2 million in 2022, then fell by 19.09% to $21.2 million in 2023, then slumped by 33.06% to $14.2 million in 2024, then fell by 18.47% to $11.6 million in 2025, then climbed by 0.42% to $11.6 million in 2026.
- Business Quant data shows GLAS's Intangibles at $11.6 million in Q1 2026, $11.6 million in Q4 2025, and $11.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 1.12 Bn |
| 10 | Glass House Brands | 866.27 Mn | 847.71 Mn | 15.77 Mn | 919,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.63 Mn |
| Dec 31, 2025 | 11.58 Mn |
| Sep 30, 2025 | 11.76 Mn |
| Jun 30, 2025 | 11.94 Mn |
| Mar 31, 2025 | 12.12 Mn |
| Dec 31, 2024 | 14.20 Mn |
| Sep 30, 2024 | 14.38 Mn |
| Jun 30, 2024 | 20.87 Mn |
| Mar 31, 2024 | 21.01 Mn |
| Dec 31, 2023 | 21.21 Mn |
| Sep 30, 2023 | 29.33 Mn |
| Jun 30, 2023 | 29.57 Mn |
| Mar 31, 2023 | 29.98 Mn |
| Dec 31, 2022 | 26.22 Mn |
| Sep 30, 2022 | 47.16 Mn |
| Jun 30, 2022 | 24.53 Mn |
| Mar 31, 2022 | 5.59 Mn |
| Dec 31, 2021 | 581,333.00 |
| Sep 30, 2021 | 4.92 Mn |
| Mar 31, 2021 | 176.92 Mn |